sexta-feira, outubro 28, 2005

Avian Flu

We bring to the attention of Global Research readers this important commentary by Dr.Joseph Mercola.
The fundamental issue is who owns the intellectual property rights over Tamiflu. The media reports suggest that the Swiss pharmaceutical company Roche will make billions. While the drug is produced by Roche, it was developed by Gilead Sciences Inc.which owns the intellectual property rights. Gilead, which has maintained a low profile, has outsourced the production to Roche.
Donald Rumsfeld was appointed Chairman of Gilead Sciences, Inc. in 1997, a position which he held in the years prior to becoming Secretary of Defense.in the Bush adminstration. Rumsfeld had been on the Board of Directors from the establishment of Gilead in 1987. As confirmed in a company press statement in 1997, Donald H. Rumsfeld assumed the position of Chairman, of GILEAD: : "Gilead is fortunate to have had Don Rumsfeld as a stalwart board member since the company's earliest days, and we are very pleased that he has accepted the Chairmanship," Dr. Riordan said.
"He has played an important role in helping to build and steer the company. His broad experience in leadership positions in both industry and government will serve us well as Gilead continues to build its commercial presence."

1 comentário:

pinhacolada disse...

Eu limitei-me a divulgar a informação de que a empresa que concebeu a vacina para a gripe das aves ter tido nos seus quadros o D.Rumsfeld...olha que coincidênca!